In Vivo Tissue-Engineered Vascular Grafts

2020 ◽  
pp. 1-21
Author(s):  
Beat H. Walpoth ◽  
Sarra de Valence ◽  
Jean-Christophe Tille ◽  
Damiano Mugnai ◽  
Tornike Sologashvili ◽  
...  
Keyword(s):  
Vascular Grafts

Antithrombogenic surface modifications in xenogenic pericardial vascular grafts: Initial in-vivo evaluation

2011 ◽  
Vol 59 (S 01) ◽  
Author(s):  
J Linneweber ◽  
F Voss ◽  
P Dohmen ◽  
W Erdbrügger ◽  
W Konertz
Keyword(s):  
Vascular Grafts ◽  
Surface Modifications ◽  
In Vivo Evaluation

Surface Modification by Nanobiomaterials for Vascular Tissue Engineering Applications

2020 ◽  
Vol 27 (10) ◽  
pp. 1634-1646 ◽  
Author(s):  
Huey-Shan Hung ◽  
Shan-hui Hsu
Keyword(s):  
Tissue Engineering ◽  
Vascular Tissue ◽  
Thrombus Formation ◽  
Vascular Grafts ◽  
Vascular Tissue Engineering ◽  
Great Success ◽  
Natural Polymers ◽  
Vascular Biomaterials

Treatment of cardiovascular disease has achieved great success using artificial implants, particularly synthetic-polymer made grafts. However, thrombus formation and restenosis are the current clinical problems need to be conquered. New biomaterials, modifying the surface of synthetic vascular grafts, have been created to improve long-term patency for the better hemocompatibility. The vascular biomaterials can be fabricated from synthetic or natural polymers for vascular tissue engineering. Stem cells can be seeded by different techniques into tissue-engineered vascular grafts in vitro and implanted in vivo to repair the vascular tissues. To overcome the thrombogenesis and promote the endothelialization effect, vascular biomaterials employing nanotopography are more bio-mimic to the native tissue made and have been engineered by various approaches such as prepared as a simple surface coating on the vascular biomaterials. It has now become an important and interesting field to find novel approaches to better endothelization of vascular biomaterials. In this article, we focus to review the techniques with better potential improving endothelization and summarize for vascular biomaterial application. This review article will enable the development of biomaterials with a high degree of originality, innovative research on novel techniques for surface fabrication for vascular biomaterials application.

scholarly journals Assessment of Electrospun Pellethane-Based Scaffolds for Vascular Tissue Engineering

Materials ◽  
2021 ◽  
Vol 14 (13) ◽  
pp. 3678
Author(s):  
Vera Chernonosova ◽  
Alexandr Gostev ◽  
Ivan Murashov ◽  
Boris Chelobanov ◽  
Andrey Karpenko ◽  
...  
Keyword(s):  
Vascular Tissue ◽  
Ex Vivo ◽  
Vascular Grafts ◽  
Wistar Rat ◽  
Graft Occlusion ◽  
Suitable Candidate ◽  
Large Animals ◽  
Cell Adhesion And Proliferation

We examined the physicochemical properties and the biocompatibility and hemocompatibility of electrospun 3D matrices produced using polyurethane Pellethane 2363-80A (Pel-80A) blends Pel-80A with gelatin or/and bivalirudin. Two layers of vascular grafts of 1.8 mm in diameter were manufactured and studied for hemocompatibility ex vivo and functioning in the infrarenal position of Wistar rat abdominal aorta in vivo (n = 18). Expanded polytetrafluoroethylene (ePTFE) vascular grafts of similar diameter were implanted as a control (n = 18). Scaffolds produced from Pel-80A with Gel showed high stiffness with a long proportional limit and limited influence of wetting on mechanical characteristics. The electrospun matrices with gelatin have moderate capacity to support cell adhesion and proliferation (~30–47%), whereas vascular grafts with bivalirudin in the inner layer have good hemocompatibility ex vivo. The introduction of bivalirudin into grafts inhibited platelet adhesion and does not lead to a change hemolysis and D-dimers concentration. Study in vivo indicates the advantages of Pel-80A grafts over ePTFE in terms of graft occlusion, calcification level, and blood velocity after 6 months of implantation. The thickness of neointima in Pel-80A–based grafts stabilizes after three months (41.84 ± 20.21 µm) and does not increase until six months, demonstrating potential for long-term functioning without stenosis and as a suitable candidate for subsequent preclinical studies in large animals.

scholarly journals Review: Tissue Engineering of Small-Diameter Vascular Grafts and Their In Vivo Evaluation in Large Animals and Humans

Cells ◽  
2021 ◽  
Vol 10 (3) ◽  
pp. 713
Author(s):  
Shu Fang ◽  
Ditte Gry Ellman ◽  
Ditte Caroline Andersen
Keyword(s):  
Animal Models ◽  
Vascular Grafts ◽  
Small Diameter ◽  
Large Animal ◽  
Large Animal Models ◽  
Graft Outcome ◽  
Limited Success ◽  
Large Animals

To date, a wide range of materials, from synthetic to natural or a mixture of these, has been explored, modified, and examined as small-diameter tissue-engineered vascular grafts (SD-TEVGs) for tissue regeneration either in vitro or in vivo. However, very limited success has been achieved due to mechanical failure, thrombogenicity or intimal hyperplasia, and improvements of the SD-TEVG design are thus required. Here, in vivo studies investigating novel and relative long (10 times of the inner diameter) SD-TEVGs in large animal models and humans are identified and discussed, with emphasis on graft outcome based on model- and graft-related conditions. Only a few types of synthetic polymer-based SD-TEVGs have been evaluated in large-animal models and reflect limited success. However, some polymers, such as polycaprolactone (PCL), show favorable biocompatibility and potential to be further modified and improved in the form of hybrid grafts. Natural polymer- and cell-secreted extracellular matrix (ECM)-based SD-TEVGs tested in large animals still fail due to a weak strength or thrombogenicity. Similarly, native ECM-based SD-TEVGs and in-vitro-developed hybrid SD-TEVGs that contain xenogeneic molecules or matrix seem related to a harmful graft outcome. In contrast, allogeneic native ECM-based SD-TEVGs, in-vitro-developed hybrid SD-TEVGs with allogeneic banked human cells or isolated autologous stem cells, and in-body tissue architecture (IBTA)-based SD-TEVGs seem to be promising for the future, since they are suitable in dimension, mechanical strength, biocompatibility, and availability.

In Vivo Tissue-Engineered Vascular Grafts

2020 ◽  
pp. 187-206
Author(s):  
Beat H. Walpoth ◽  
Sarra de Valence ◽  
Jean-Christophe Tille ◽  
Damiano Mugnai ◽  
Tornike Sologashvili ◽  
...  
Keyword(s):  
Vascular Grafts

scholarly journals Histological Reactions and the In Vivo Patency Rates of Small Silk Vascular Grafts in a Canine Model

2017 ◽  
Vol 10 (2) ◽  
pp. 132-138 ◽  
Author(s):  
Makoto Haga ◽  
Satoshi Yamamoto ◽  
Hiroyuki Okamoto ◽  
Katsuyuki Hoshina ◽  
Tetsuro Asakura ◽  
...  
Keyword(s):  
Vascular Grafts ◽  
Canine Model ◽  
Histological Reactions

Matrix Engineering: Remodeling of Dense Fibrillar Collagen Vascular Grafts in Vivo

1993 ◽  
pp. 190-198
Author(s):  
Crispin B. Weinberg ◽  
Kimberlie D. O’Neil ◽  
Robert M. Carr ◽  
John F. Cavallaro ◽  
Bruce A. Ekstein ◽  
...  
Keyword(s):  
Vascular Grafts ◽  
Fibrillar Collagen

scholarly journals Surgical Technique for the Implantation of Tissue Engineered Vascular Grafts and Subsequent In Vivo Monitoring

10.3791/52354 ◽  
2015 ◽  
Author(s):  
Maxwell T. Koobatian ◽  
Carmon Koenigsknecht ◽  
Sindhu Row ◽  
Stelios Andreadis ◽  
Daniel Swartz
Keyword(s):  
Surgical Technique ◽  
Vascular Grafts

Heat-denatured albumin-coated Dacron vascular grafts: Physical characteristics and in vivo performance

1986 ◽  
Vol 4 (2) ◽  
pp. 136-143 ◽  
Author(s):  
John D. Rumisek ◽  
Charles E. Wade ◽  
Daniel E. Brooks ◽  
Carlin V. Okerberg ◽  
Michael J. Barry ◽  
...  
Keyword(s):  
Vascular Grafts ◽  
Physical Characteristics
Sign in / Sign up

Export Citation Format

Share Document